Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
Settings
DSCI Derma Sciences Inc. daily Stock Chart
DSCI [NASD]
Derma Sciences Inc.
Index- P/E- EPS (ttm)-1.50 Insider Own3.30% Shs Outstand25.80M Perf Week-1.75%
Market Cap86.95M Forward P/E- EPS next Y-0.29 Insider Trans7.73% Shs Float24.21M Perf Month-21.99%
Income-38.40M PEG- EPS next Q-0.42 Inst Own89.70% Short Float2.67% Perf Quarter-35.19%
Sales87.10M P/S1.00 EPS this Y-15.70% Inst Trans13.81% Short Ratio2.41 Perf Half Y-50.07%
Book/sh4.05 P/B0.83 EPS next Y81.30% ROA-30.10% Target Price6.83 Perf Year-60.81%
Cash/sh1.91 P/C1.76 EPS next 5Y- ROE-33.60% 52W Range3.04 - 9.23 Perf YTD-26.26%
Dividend- P/FCF- EPS past 5Y-45.30% ROI-31.80% 52W High-63.49% Beta1.16
Dividend %- Quick Ratio5.60 Sales past 5Y11.50% Gross Margin38.20% 52W Low10.85% ATR0.32
Employees299 Current Ratio7.30 Sales Q/Q9.90% Oper. Margin-44.50% RSI (14)42.49 Volatility11.81% 10.22%
OptionableYes Debt/Eq0.00 EPS Q/Q22.20% Profit Margin-44.20% Rel Volume0.13 Prev Close3.60
ShortableYes LT Debt/Eq0.00 EarningsMar 10 BMO Payout- Avg Volume267.73K Price3.37
Recom2.00 SMA20-3.52% SMA50-17.43% SMA200-41.79% Volume34,373 Change-6.39%
Jan-08-16Reiterated Oppenheimer Outperform $8 → $7
Dec-03-15Reiterated ROTH Capital Buy $16 → $9.50
Nov-13-15Reiterated Piper Jaffray Neutral $6 → $4
Nov-13-15Reiterated Oppenheimer Outperform $17 → $8
Aug-14-14Reiterated Oppenheimer Outperform $19 → $18
Mar-17-14Reiterated Oppenheimer Outperform $19 → $21
Jul-06-11Initiated Oppenheimer Outperform $21
Feb-09-11Reiterated Rodman & Renshaw Mkt Outperform $13 → $25
May-14-10Initiated Rodman & Renshaw Mkt Outperform $13
Feb-03-16 10:40AM  Becton, Dickinson Beats Q1 Earnings, FY16 View Raised
Jan-20-16 08:00AM  BioLargo Closes Financing To Advance Its Novel Wound Care Products Accesswire
Jan-07-16 07:30AM  Derma Sciences Provides 2015 Preliminary Net Sales and Introduces 2016 Financial Guidance Business Wire -13.89%
Dec-22-15 09:51AM  Derma Sciences, Inc. Earnings Analysis: Q3, 2015 By the Numbers
08:36AM  Is Derma Sciences (DSCI) Stock a Solid Choice Right Now?
Dec-21-15 05:14PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:30AM  Derma Sciences Announces Leadership and CEO Transition Business Wire
Dec-16-15 11:10AM  Starboard Trims Office Depot Stake Amid FTC Challenging Merger with Staples; Broadfin Capital Buys More Derma Sciences Inc. (DSCI) at Insider Monkey
Dec-08-15 01:17PM  DERMA SCIENCES, INC. Financials
Dec-01-15 06:01PM  Is Independence Contract Drilling Inc (ICD) A Good Stock To Buy? at Insider Monkey
Nov-30-15 12:59PM  Is Derma Sciences Inc (DSCI) a Good Buy? at Insider Monkey
Nov-26-15 07:32AM  Fortress Biotech Inc (FBIO)Hedge Funds Are Snapping Up at Insider Monkey
Nov-24-15 04:00PM  Derma Sciences to Participate in the 27th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-20-15 08:37AM  How Derma Sciences (DSCI) Stock Stands Out in a Strong Industry
Nov-16-15 07:30AM  Derma Sciences to Participate in the Canaccord Genuity 2015 Medical Technology & Diagnostics Forum Business Wire
Nov-12-15 12:33PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud by Derma Sciences, Inc. and Certain Officers and Directors Business Wire -27.86%
11:05AM  Why Are These Five Stocks Plunging on Thursday? at Insider Monkey
10:45AM  Derma Sciences (DSCI) Stock Falls After Ending Drug Trial at TheStreet
08:30AM  Derma Sciences Inc Business Update Call scheduled for 8:30 am ET today
07:48AM  Derma Sciences to stop developing foot-ulcer drug
07:30AM  Derma Sciences Announces Results of Futility Analyses for Phase 3 Clinical Trials of Aclerastide in Diabetic Foot Ulcer Healing Business Wire
Nov-11-15 04:05PM  Derma Sciences to Hold Conference Call on November 12 to Discuss Data Monitoring Committee Pre-Specified Interim Analysis of the Aclerastide Phase 3 Trials Business Wire
Nov-09-15 10:00AM  Derma Sciences Inc Earnings Call scheduled for 10:00 am ET today +10.76%
07:45AM  Derma Sciences reports 3Q loss
07:30AM  Derma Sciences Reports Third Quarter 2015 Financial Results Business Wire
07:07AM  Q3 2015 Derma Sciences Inc Earnings Release - Before Market Open
Nov-06-15 05:46PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Nov-03-15 08:30AM  Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 9th Business Wire
Oct-06-15 02:58PM  Roth Capital Reiterates Buy on Three Pharma Stocks at Investopedia
Oct-05-15 02:38PM  Three Pharma Picks That Could Double or Triple at Barrons.com
Oct-02-15 10:50AM  Derma Sciences, Inc. Earnings Q2, 2015
Sep-21-15 02:37PM  ETFs with exposure to Derma Sciences, Inc. : September 21, 2015
10:50AM  Derma Sciences, Inc. breached its 50 day moving average in a Bullish Manner : September 21, 2015
Sep-02-15 01:30PM  Three Stocks That Could Double Your Investment
Aug-20-15 03:41PM  Edited Transcript of DSCI earnings conference call or presentation 10-Aug-15 3:00pm GMT
Aug-10-15 11:04AM  CORRECTING and REPLACING Derma Sciences Reports Second Quarter Financial Results Business Wire
11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
07:39AM  Derma Sciences reports 2Q loss
07:07AM  Q2 2015 Derma Sciences Inc Earnings Release - Before Market Open
Aug-07-15 04:29PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
Aug-06-15 07:30AM  Derma Sciences to Present at the Canaccord Genuity Global Growth Conference Business Wire
Aug-03-15 02:21PM  Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 10th Business Wire
Jun-25-15 08:30AM  Derma Sciences Announces Publication in Advances in Wound Care Business Wire
Jun-18-15 07:30AM  Derma Sciences Completes Non-Clinical Aclerastide Toxicology Program Business Wire
Jun-17-15 07:30AM  Derma Sciences Announces Medicare Coverage Reinstated For MEDIHONEY® Products with Reimbursable Codes by Centers for Medicare & Medicaid Services Business Wire +7.87%
Jun-04-15 08:37AM  Sell These 7 Health Care Supplies Companies Now at TheStreet
May-29-15 05:21PM  DERMA SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-19-15 07:30AM  Derma Sciences Provides Update on Aclerastide Phase 3 Trials Business Wire
May-11-15 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
07:15AM  Derma Sciences reports 1Q loss
07:07AM  Q1 2015 Derma Sciences Inc Earnings Release - Before Market Open
07:00AM  Derma Sciences Reports First Quarter 2015 Financial Results Business Wire
May-08-15 05:24PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
May-05-15 05:43PM  Derma Sciences to Hold First Quarter Financial Results Conference Call on May 11Th at noodls
03:32PM  Derma Sciences to Hold First Quarter Financial Results Conference Call on May 11Th Business Wire
Apr-30-15 09:46AM  Derma Sciences to Present Clinical Data Demonstrating Efficacy in Tissue Regeneration at the Spring Symposium on Advanced Wound Care at noodls
09:00AM  Derma Sciences to Present Clinical Data Demonstrating Efficacy in Tissue Regeneration at the Spring Symposium on Advanced Wound Care PR Newswire
Mar-19-15 09:33AM  Broadfin Buffs Up on Zogenix, Inc. (ZGNX) and Derma Sciences Inc (DSCI) at Insider Monkey +9.26%
Mar-12-15 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
07:57AM  Derma Sciences reports 4Q loss
07:41AM  Derma Sciences Reports Fourth Quarter and Year Ended Financial Results at noodls
07:30AM  Derma Sciences Reports Fourth Quarter and Year Ended Financial Results Business Wire
07:07AM  Q4 2014 Derma Sciences Inc Earnings Release - Time Not Supplied
Mar-11-15 05:24PM  DERMA SCIENCES, INC. Files SEC form 10-K, Annual Report
Mar-09-15 07:35AM  Derma Sciences Names Pharmaceutical Development Leader John Caminis, M.D. as Chief Medical Officer at noodls
07:30AM  Derma Sciences Names Pharmaceutical Development Leader John Caminis, M.D. as Chief Medical Officer Business Wire
Mar-04-15 11:09AM  Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 12th at noodls
10:43AM  Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 12th Business Wire
08:30AM  Derma Sciences to Present at the 27th Annual Roth Conference Business Wire
Mar-02-15 02:53PM  Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point Partners at Insider Monkey
Jan-22-15 09:00AM  Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement PR Newswire
Jan-08-15 07:30AM  Derma Sciences Introduces 2015 Financial Guidance and Provides 2014 Preliminary Net Sales Business Wire
Dec-17-14 09:03AM  New Consensus Guidelines and Practical Recommendations Published on the Optimal Use of Off-Loading in Diabetic Foot Ulcer Treatment PR Newswire
Nov-28-14 10:15AM  Insider Trading Alert - MNTA, DOC And DSCI Traded By Insiders at TheStreet
Nov-25-14 02:05PM  Derma Sciences To Participate in Two Upcoming Investor Conferences in December Business Wire
Nov-14-14 09:21AM  Derma Sciences to Participate in Canaccord Genuity Medical Technologies and Diagnostics Forum Business Wire
Nov-10-14 07:39AM  Derma Sciences posts 3Q loss AP -6.18%
07:30AM  Derma Sciences Reports Third Quarter Financial Results Business Wire
Nov-07-14 05:27PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
06:19AM  Is a Surprise Coming for Derma Sciences (DSCI) This Earnings Season? Zacks
Nov-06-14 07:30AM  Newly Published Final CMS Payments for 2015 Favorably Impact Derma Sciences TCC-EZ® and AMNIOEXCEL® Business Wire
Nov-04-14 08:30AM  Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th Business Wire
Oct-23-14 11:58AM  Derma Sciences Presented Clinical Evidence And Data On Its Tissue Regeneration Products for Diabetic Foot Ulcers At Fall 2014 Symposium On Advanced Wound Care PR Newswire
Oct-17-14 02:37PM  Derma Sciences Showcases "Off-Loading Your Diabetic Foot Ulcer, An Actor's Story," a Patient Video Featuring Actor and Director Stephen Furst and his Experience with TCC-EZ® PR Newswire
Aug-12-14 09:16AM  Derma Sciences to Present at Canaccord Genuity 34th Annual Growth Conference on August 14 Business Wire
Aug-07-14 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today CCBN -7.20%
07:30AM  Derma Sciences Reports Second Quarter Financial Results Business Wire
07:07AM  Q2 2014 Derma Sciences, Inc. Earnings Release - Before Market Open CCBN
Aug-06-14 05:09PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-01-14 07:30AM  Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 7th Business Wire
Jul-25-14 07:30AM  Derma Sciences CEO Discusses Continued Growth of MEDIHONEY® at Comvita Annual Meeting of Shareholders Business Wire
Jul-22-14 09:02AM  Derma Sciences announces Veterans Administration adds AMNIOEXCEL® to its Federal Supply Schedule Business Wire
Jun-19-14 07:47AM  Derma (DSCI) is in Overbought Territory: What's Next? Zacks
Jun-13-14 03:59PM  Derma Sciences, Inc. to Webcast June 17th Analyst Day Business Wire
May-29-14 09:00PM  [video] Derma Sciences CEO: Medihoney Sales Sweet and Getting Sweeter at TheStreet
May-23-14 04:50PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o EDGAR Online
May-22-14 11:10AM  Derma Sciences management to meet with Oppenheimer at theflyonthewall.com
May-09-14 07:39PM  Derma Sciences' (DSCI) CEO Ed Quilty on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
May-08-14 11:00AM  Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN -8.31%
07:36AM  Derma Sciences affirms FY14 net sales view $92M, consensus $91.78M at theflyonthewall.com
Derma Sciences, Inc. operates as a tissue regeneration company in the wound care market. Its Advanced Wound Care segment offers MEDIHONEY dressings for managing non-chronic and hard-to-heal wounds, including chronic ulcers, burns, and post-operative wounds; TCC-EZ system for patients with diabetic foot ulcers; AMNIOEXCEL for tissue repair, reconstruction, and replacement; and AMNIOMATRIX that is used as a wound covering in the treatment of localized tissue defects. This segment also provides XTRASORB dressings, which convert fluid within the dressings to a gel and lock the exudates into the dressings; BIOGUARD dressings for prophylactic use in the prevention of hospital or community acquired infections through wound sites; ALGICELL AG antimicrobial dressings; and occlusive dressings, such as hydrocolloids, foams, hydrogels, alginates, additional silver antimicrobial dressings, cleansers, and DERMAGRAN products. The company's Traditional Wound Care segment offers gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages, and other compression devices; adhesive bandages and related first aid products; private-label wound care products; wound closure strips, nasal tube fasteners, and catheter fasteners; and general purpose and specialized skin care products. Its Pharmaceutical Wound Care segment develops DSC127, an angiotensin analog that is in Phase III clinical trials for the treatment of diabetic foot ulcers, and preclinical testing for scar reduction. The company sells its products to various health care providers, including wound care centers, extended care facilities, acute care facilities, home health care agencies, physicians' offices, nursing homes, hospitals, and clinics through direct sales and manufacturers' representatives, independent distributors, and retail channels in the United States, Canada, and the United Kingdom. Derma Sciences, Inc. was founded in 1984 and is headquartered in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CONJEEVARAM SRINIDirectorAug 18Buy6.501,1007,15063,942Aug 18 05:40 PM
WILLS STEPHEN TDirectorAug 14Buy6.593,00019,770119,201Aug 14 04:26 PM
NAVARRO SAMUEL EDirectorAug 14Buy6.491,2558,14520,000Aug 14 04:21 PM
WESSON BRUCE FDirectorAug 13Buy6.5810,00065,80094,963Aug 14 07:20 PM
COLE ROBERT CSee RemarksAug 13Buy6.735,00033,65071,723Aug 14 06:27 PM
PAUL AMY SDirectorAug 13Buy6.615,00033,05032,750Aug 14 04:28 PM
QUILTY EDWARD JPresident & CEOAug 13Buy6.6515,00099,750193,757Aug 14 04:27 PM
WILLS STEPHEN TDirectorAug 13Buy6.397,00044,730116,201Aug 14 04:26 PM
MOUSSA ROBERT GDirectorAug 13Buy6.615,00033,05063,896Aug 14 04:24 PM
NAVARRO SAMUEL EDirectorAug 13Buy6.518,74556,93018,745Aug 14 04:21 PM
Hewlett BrettDirectorJun 12Sale7.1712,00086,040898,630Jun 16 06:27 PM
WILLS STEPHEN TDirectorMay 12Option Exercise3.368,75029,40098,359May 13 05:41 PM
CONJEEVARAM SRINIDirectorMay 12Option Exercise3.368,75029,40057,000May 13 05:40 PM
MOUSSA ROBERT GDirectorMar 18Option Exercise3.3611,25037,80053,500Mar 20 05:29 PM
Wolfenson BarrySee RemarksFeb 27Option Exercise4.006,25025,00084,568Mar 03 05:28 PM
COLE ROBERT CSee RemarksFeb 27Option Exercise4.0014,53258,12874,062Mar 03 05:25 PM
QUILTY EDWARD JPresident & CEOFeb 27Option Exercise4.0024,21996,876190,988Mar 03 05:21 PM
Eigner FredericExecutive VP - OperationsFeb 09Option Exercise4.0015,23560,94058,533Feb 11 05:14 PM